Literature DB >> 7708196

Cranial MRI in ataxia-telangiectasia.

F Sardanelli1, R C Parodi, C Ottonello, P Renzetti, S Saitta, E Lignana, G L Mancardi.   

Abstract

We examined five males with laboratory-confirmed ataxia-telangiectasia (AT), aged 9-28 years, several times by MRI (9 examinations: 5 at 0.15 T, 3 at 0.5 T, 1 at 1.5 T). Intermediate, T1-, T2- and T2*-weighted spin-echo and gradient-echo sequences were performed. All patients showed vermian atrophy, enlarged fourth ventricle and cisterna magna; four showed cerebellar hemisphere atrophy; two enlarged infracerebellar subarachnoid spaces and four patients had sinusitis. No focal areas of abnormal signal were seen in the brain, diffuse high signal was found in the central cerebral white matter of the oldest patient. AT is an important human model of inherited cancer susceptibility and multisystem ageing; as in xeroderma pigmentosum and other "breakage syndromes", ionising radiation should be avoided. When imaging is necessary, MRI should be preferred to CT in patients known or suspected to have AT and those with undefined paediatric ataxias of nontraumatic origin. If atrophy of only the cerebellum, especially the vermis, is noted, laboratory research should be performed to confirm the diagnosis of AT.

Entities:  

Mesh:

Year:  1995        PMID: 7708196     DOI: 10.1007/bf00588526

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  38 in total

1.  Magnetic resonance imaging in familial paroxysmal ataxia.

Authors:  A Vighetto; J C Froment; M Trillet; G Aimard
Journal:  Arch Neurol       Date:  1988-05

2.  Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy.

Authors:  H Saito; T Yanagisawa
Journal:  Tohoku J Exp Med       Date:  1989-05       Impact factor: 1.848

3.  Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia.

Authors:  T A Waldmann; K R McIntire
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

Review 4.  Occurrence of malignancy in immunodeficiency diseases. A literature review.

Authors:  R A Gatti; R A Good
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

5.  Ataxia-telangiectasis: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia.

Authors:  T A Waldmann; J Misiti; D L Nelson; K H Kraemer
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

Review 6.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

7.  Malignant neoplasms in the families of patients with ataxia-telangiectasia.

Authors:  M Swift; L Sholman; M Perry; C Chase
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

Review 8.  [Ataxia telangiectasia: what impact in clinical oncology?].

Authors:  D Stoppa-Lyonnet; A Aurias
Journal:  Bull Cancer       Date:  1992       Impact factor: 1.276

9.  Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia.

Authors:  K Wessel; G Schroth; H C Diener; W Müller-Forell; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

10.  G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes.

Authors:  R Parshad; K K Sanford; G M Jones; R E Tarone
Journal:  Cancer Genet Cytogenet       Date:  1985-01-01
View more
  11 in total

1.  Abnormal white matter signal in ataxia telangiectasia.

Authors:  J J Ciemins; A L Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

Review 2.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  Proton spectroscopy and imaging at 3T in ataxia-telangiectasia.

Authors:  L I Wallis; P D Griffiths; S J Ritchie; C A J Romanowski; G Darwent; I D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 4.  Ataxia-telangiectasia and related diseases.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 5.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

6.  Cerebral abnormalities in adults with ataxia-telangiectasia.

Authors:  D D M Lin; P B Barker; H M Lederman; T O Crawford
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

Review 7.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

Review 8.  [Primary central nervous system degeneration in elderly patients. Characteristic imaging features].

Authors:  S Weidauer; M Nichtweiss; H Lanfermann
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

9.  Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study.

Authors:  Ishani Sahama; Kate Sinclair; Simona Fiori; James Doecke; Kerstin Pannek; Lee Reid; Martin Lavin; Stephen Rose
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

Review 10.  Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging.

Authors:  Enricomaria Mormina; Maria Petracca; Giulia Bommarito; Niccolò Piaggio; Sirio Cocozza; Matilde Inglese
Journal:  World J Radiol       Date:  2017-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.